These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3220920)

  • 1. Isolation of gentamicin C compounds from culture filtrates of Micromonospora purpurea.
    Jork H; Kunz FR
    J Chromatogr; 1988 Oct; 450(1):115-9. PubMed ID: 3220920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of gentamicin antibiotics produced by Micromonospora purpurea.
    Abou-Zeid AA; Eissa AI; Salem HM
    Zentralbl Bakteriol Naturwiss; 1978; 133(4):362-8. PubMed ID: 726708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolites of gentamicin-producing Micromonospora species I. Isolation and identification of metabolites.
    Bérdy J; Pauncz JK; Vajna ZM; Horváth G; Gyimesi J; Koczka I
    J Antibiot (Tokyo); 1977 Nov; 30(11):945-54. PubMed ID: 591461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of gentamicin C-complex into five components by Craig distribution.
    Byrne KM; Kershner AS; Maehr H; Marquez JA; Schaffner CP
    J Chromatogr; 1977 Jan; 131():191-203. PubMed ID: 856852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gentamicin antibiotics. 6. Gentamicin C2b, an aminoglycoside antibiotic produced by Micromonospora purpurea mutant JI-33.
    Daniels PJ; Luce C; Nagabhushan TL
    J Antibiot (Tokyo); 1975 Jan; 28(1):35-41. PubMed ID: 1092638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of 3″-demethyl-gentamicin C components by genN disruption strain of Micromonospora echinospora and test their antimicrobial activities in vitro.
    Ni X; Zong T; Zhang H; Gu Y; Huang M; Tian W; Xia H
    Microbiol Res; 2016 Apr; 185():36-44. PubMed ID: 26946376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sagamicin and the related aminoglycosides: fermentation and biosynthesis. I. Biosynthetic studies with the blocked mutants of Micromonospora sagamiensis.
    Kase H; Odakura Y; Nakayama K
    J Antibiot (Tokyo); 1982 Jan; 35(1):1-9. PubMed ID: 7082452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a gentamicin C1a-overproducing strain of Micromonospora purpurea by inactivation of the gacD gene.
    Li D; Li H; Ni X; Zhang H; Xia H
    Microbiol Res; 2013 Jun; 168(5):263-7. PubMed ID: 23305768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational biosynthesis by idiotrophs of Micromonospora purpurea. II. Conversion of non-amino containing cyclitols to aminoglycoside antibiotics.
    Daum SJ; Rosi D; Goss WA
    J Antibiot (Tokyo); 1977 Jan; 30(1):98-105. PubMed ID: 838635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation, a new approach to aminoglycoside biosynthesis: II. Gentamicin.
    Testa RT; Tilley BC
    J Antibiot (Tokyo); 1976 Feb; 29(2):140-6. PubMed ID: 931800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micromonospora-produced gentamicin components.
    Lee BK; Condon RG; Wagman GH; Katz E
    Antimicrob Agents Chemother; 1976 Jan; 9(1):151-9. PubMed ID: 1259389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational biosynthesis by idiotrophs of Micromonospora purpurea. I. Conversion of aminocyclitols to new aminoglycoside antibiotics.
    Rosi D; Goss WA; Daum SJ
    J Antibiot (Tokyo); 1977 Jan; 30(1):88-97. PubMed ID: 320170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of nutritional requirements for gentamicin production by Micromonospora echinospora.
    Himabindu M; Jetty A
    Indian J Exp Biol; 2006 Oct; 44(10):842-8. PubMed ID: 17131916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibiotic with activity against gram-positive bacteria from the gentamicin-producing strain of Micromonospora purpurea.
    Rusnak K; Troyanovich J; Mierzwa R; Chu M; Patel M; Weinstein M
    Appl Microbiol Biotechnol; 2001 Aug; 56(3-4):502-3. PubMed ID: 11549027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive Production of Gentamicin C1a from
    Wei Z; Shi X; Lian R; Wang W; Hong W; Guo S
    Antibiotics (Basel); 2019 Dec; 8(4):. PubMed ID: 31847403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dependence of the component makeup of the gentamicin complex on Micromonospora purpurea var. violacea 1935 cultivation conditions].
    Laznikova TN; Krasnova TP; Lipina EV; Orlova NV
    Antibiotiki; 1978 Jun; 23(6):499-503. PubMed ID: 677834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic pathway leading to gentamicin C2b.
    Lee BK; Nagabhushan TL; Condon RG; Shimonaski G; Kalyanpur MG; Patel M; Waitz JA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):589-91. PubMed ID: 525999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sagamicin and the related aminoglycosides: fermentation and biosynthesis. III. Isolation and characterization of Micromonospora sagamiensis mutants blocked in gentamicin C1 pathway.
    Odakura Y; Kase H; Nakayama K
    J Antibiot (Tokyo); 1983 Feb; 36(2):125-30. PubMed ID: 6833127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of gentamicins by Micromonospora purpurea.
    Abou-Zeid AZ; Salem HM; Eissa AE
    Zentralbl Bakteriol Naturwiss; 1978; 133(3):261-75. PubMed ID: 696047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isocratic separation of underivatized gentamicin components, 1H NMR assignment and protonation pattern.
    Lesniak W; Mc Laren J; Harris WR; Pecoraro VL; Schacht J
    Carbohydr Res; 2003 Nov; 338(24):2853-62. PubMed ID: 14667706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.